AAAAAA
Results: 1-25/32
Authors:
Andrew, M
Ansell, JL
Becker, DM
Becker, RC
Triplett, DA
Citation: M. Andrew et al., Prothrombin measurement using a patient self-testing system, AM J CLIN P, 115(2), 2001, pp. 280-287
Authors:
Andrew, M
Ansell, JL
Becker, DM
Becker, RC
Triplett, DA
Citation: M. Andrew et al., Point-of-care prothrombin time measurement for professional and patient self-testing use - A multicenter clinical experience, AM J CLIN P, 115(2), 2001, pp. 288-296
Authors:
Becker, RC
Citation: Rc. Becker, Anticoagulation and the heart, J THROMB TH, 12(1), 2001, pp. 41-52
Authors:
Kimmelstiel, C
Phang, R
Rehman, A
Rand, W
Miele, R
Rhofiry, J
MacIsaac, DA
Gouveia, W
Denier, D
Becker, RC
Citation: C. Kimmelstiel et al., Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention, J THROMB TH, 11(3), 2001, pp. 203-209
Authors:
Becker, RC
Burns, M
Every, N
Maynard, C
Frederick, P
Spencer, FA
Gore, JM
Lambrew, C
Citation: Rc. Becker et al., Early clinical outcomes and routine management of patients with non-ST-segment elevation myocardial infarction - A nationwide perspective, ARCH IN MED, 161(4), 2001, pp. 601-607
Authors:
Spencer, FA
Goldberg, RJ
Frederick, PD
Malmgren, J
Becker, RC
Gore, JM
Citation: Fa. Spencer et al., Age and the utilization of cardiac catheterization following uncomplicatedfirst acute myocardial infarction treated with thrombolytic therapy (The second national registry of myocardial infarction [NRMI-2]), AM J CARD, 88(2), 2001, pp. 107-111
Authors:
Li, YF
Spencer, FA
Becker, RC
Citation: Yf. Li et al., Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alpha IIb/beta(3)) receptor-directed platelet inhibition, AM HEART J, 142(2), 2001, pp. 204-210
Authors:
Becker, RC
Eisenberg, P
Turpie, AGG
Citation: Rc. Becker et al., Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: Fundamental principles and the contribution of platelets and thrombin, AM HEART J, 141(6), 2001, pp. 1025-1037
Authors:
Becker, RC
Pezzella, AT
Citation: Rc. Becker et At. Pezzella, Myocardial rupture - Pathobiology, diagnosis, medical management, and surgical intervention, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 639-687
Authors:
Raabe, D
Becker, RC
Citation: D. Raabe et Rc. Becker, Coupling of a crystal plasticity finite-element model with a probabilisticcellular automaton for simulating primary static recrystallization in aluminium, MODEL SIM M, 8(4), 2000, pp. 445-462
Authors:
Becker, RC
Burns, M
Gore, JM
Lambrew, C
French, W
Rogers, WJ
Citation: Rc. Becker et al., Early and pre-discharge aspirin administration among patients with acute myocardial infarction: Current clinical practice and trends in the United States, J THROMB TH, 9(3), 2000, pp. 207-215
Authors:
Spencer, FA
Ball, SP
Zhang, QL
Liu, LB
Benoit, S
Becker, RC
Citation: Fa. Spencer et al., Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralization, J THROMB TH, 9(3), 2000, pp. 223-228
Authors:
Becker, RC
Citation: Rc. Becker, Key references: Anticoagulation monitoring, J THROMB TH, 9(1), 2000, pp. 69-76
Authors:
Becker, RC
Citation: Rc. Becker, Key references: Cardiac rupture, J THROMB TH, 9(1), 2000, pp. 77-80
Authors:
Becker, RC
Citation: Rc. Becker, Platelet surface physiology and its importance in pharmacotherapy design and development: The adenosine diphosphate receptor antagonists, J THROMB TH, 10(1), 2000, pp. 35-53
Authors:
Li, YF
Spencer, FA
Ball, S
Becker, RC
Citation: Yf. Li et al., Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: Potential contributing mechanism of benefit in acute coronary syndromes, J THROMB TH, 10(1), 2000, pp. 69-76
Authors:
Becker, RC
Citation: Rc. Becker, Heparin-induced thrombocytopenia: Supplement to the Journal of Thrombosis and Thrombolysis, J THROMB TH, 10, 2000, pp. S5-S5
Authors:
Becker, RC
Citation: Rc. Becker, Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting, J THROMB TH, 10, 2000, pp. S59-S68
Authors:
Pourboghrat, F
Karabin, ME
Becker, RC
Chung, K
Citation: F. Pourboghrat et al., A hybrid membrane/shell method for calculating springback of anisotropic sheet metals undergoing axisymmetric loading, INT J PLAST, 16(6), 2000, pp. 677-700
Authors:
Becker, RC
Citation: Rc. Becker, Heparins in management of acute coronary syndromes without ST-segment elevation, LANCET, 355(9219), 2000, pp. 1926-1928
Authors:
Becker, RC
Citation: Rc. Becker, Low-molecular-weight heparin as optimal solution to therapeutic heparinization - Reply, AM HEART J, 139(3), 2000, pp. 560-561
Authors:
Becker, RC
Spencer, FA
Citation: Rc. Becker et Fa. Spencer, Hematological evaluation of stroke risk, PREVENTION OF ISCHEMIC STROKE, 2000, pp. 51-77
Authors:
Dickson, EW
Reinhardt, CP
Renzi, FP
Becker, RC
Porcaro, WA
Heard, SO
Citation: Ew. Dickson et al., Ischemic preconditioning may be transferable via whole blood transfusion: Preliminary evidence, J THROMB TH, 8(2), 1999, pp. 123-129
Authors:
Becker, RC
Ansell, J
Citation: Rc. Becker et J. Ansell, Special issue: Thrombosis, thrombolysis, and anticoagulation for the clinician: Guidelines for safe and effective management of patients with thrombotic disorders - Introduction, J THROMB TH, 7(2), 1999, pp. 89-89
Authors:
Spencer, FA
Becker, RC
Citation: Fa. Spencer et Rc. Becker, Diagnosis and management of inherited and acquired thrombophilias, J THROMB TH, 7(2), 1999, pp. 91-104